- Munemura, R., Maehara, T., Murakami, Y., Koga, R., Aoyagi, R., Kaneko, N., Doi, A., Perugino, C. A., Della-Torre, E., Saeki, T., Sato, Y., Yamamoto, H., Kiyoshima, T., Stone, J. H., Pillai, S., & Nakamura, S. (2022). Distinct disease-specific Tfh cell populations in 2 different fibrotic diseases: IgG4-related disease and Kimura disease. Journal of Allergy and Clinical Immunology, 150(2), 440-455.e17. https://doi.org/10.1016/j.jaci.2022.03.034
- Yokoyama, K., Mitoma, H., Kawano, S., Yamauchi, Y., Wang, Q., Ayano, M., Kimoto, Y., Ono, N., Arinobu, Y., Akashi, K., Horiuchi, T., & Niiro, H. (2022). CEACAM 1, 3, 5 and 6 -positive classical monocytes correlate with interstitial lung disease in early systemic sclerosis. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.1016914
- Hatano, S., Mine, K., Noguchi, N., Matsumoto, M., Baba, Y., & Yoshikai, Y. (2022). MHC class II inhibits the generation of IL‐17A + Vγ6 γδ T cells in the thymus at perinatal stage. European Journal of Immunology, 52(8), 1366–1368. https://doi.org/10.1002/eji.202149542
- Kanemura, H., Hayashi, H., Tomida, S., Tanizaki, J., Suzuki, S., Kawanaka, Y., Tsuya, A., Fukuda, Y., Kaneda, H., Kudo, K., Takahama, T., Imai, R., Haratani, K., Chiba, Y., Otani, T., Ito, A., Sakai, K., Nishio, K., & Nakagawa, K. (2022). The Tumor Immune Microenvironment and Frameshift Neoantigen Load Determine Response to PD-L1 Blockade in Extensive-Stage SCLC. JTO Clinical and Research Reports, 3(8), 100373. https://doi.org/10.1016/j.jtocrr.2022.100373
- Miyata, N., Ito, T., Nakashima, M., Fujii, S., & Kuge, O. (2022). Mitochondrial phosphatidylethanolamine synthesis affects mitochondrial energy metabolism and quiescence entry through attenuation of Snf1/AMPK signaling in yeast. The FASEB Journal, 36(7). https://doi.org/10.1096/fj.202101600RR
- Shinkawa, T., Ohuchida, K., Mochida, Y., Sakihama, K., Iwamoto, C., Abe, T., Ideno, N., Mizuuchi, Y., Shindo, K., Ikenaga, N., Moriyama, T., Nakata, K., Oda, Y., & Nakamura, M. (2022). Subtypes in pancreatic ductal adenocarcinoma based on niche factor dependency show distinct drug treatment responses. Journal of Experimental & Clinical Cancer Research, 41(1), 89. https://doi.org/10.1186/s13046-022-02301-9
- Otsuka, H., Yokomizo, H., Nakamura, S., Izumi, Y., Takahashi, M., Obara, S., Nakao, M., Ikeda, Y., Sato, N., Sakamoto, R., Miyachi, Y., Miyazawa, T., Bamba, T., & Ogawa, Y. (2022). Differential effect of canagliflozin, a sodium–glucose cotransporter 2 (SGLT2) inhibitor, on slow and fast skeletal muscles from nondiabetic mice. Biochemical Journal, 479(3), 425–444. https://doi.org/10.1042/BCJ20210700
Author:
cellinnovatoradmin
Filed Under Category:
未分類
Article
Comments:
No Comments